Navigation

Investiment.io
Financial analysis platform

Johnson & Johnson

JNJ โ€ข NYSE

$282.55
โ–ผ3.20 (1.12%)โ€ข REGULAR

Johnson & Johnson

$282.55
โ–ผ1.1%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading

๐Ÿ“ˆ Advanced DCF Valuation

Professional-grade discounted cash flow analysis with scenario modeling for JNJ

Healthcare โ€ข Drug Manufacturers - General โ€ข Market Cap: $680,185,515,658.30

Scenario Analysis

Compare different scenarios to understand valuation sensitivity

๐Ÿ”ป-97.6% upside

Conservative Case

$6.89

๐Ÿ“Š-96.3% upside

Base Case

$10.44

๐Ÿ”บ-95.1% upside

Optimistic Case

$13.84

๐Ÿ’ฐMarket Price

Current Price

$282.55

DCF Model & Results

Detailed cash flow projections and valuation analysis

๐Ÿ’ต Enhanced Cash Flow Projections

YearRevenueGrowth %Operating Margin %NOPATCapExFCFPV of FCF
1$98,902,650,000.005.0%15.0%$11,719,964,025.00$5,200,440,000.00$9,463,055,275.00$8,629,569,616.95
2$102,996,746,072.874.1%11.3%$9,153,835,807.23$5,123,332,028.16$7,099,935,680.89$5,904,320,636.50
3$106,786,587,889.733.7%8.4%$7,117,993,499.03$5,034,886,674.66$5,267,755,251.97$3,994,835,201.64
4$110,224,718,269.903.2%6.3%$5,510,374,782.88$4,925,992,713.83$3,873,932,965.25$2,679,064,320.64
5$113,266,568,589.062.8%4.7%$4,246,832,650.79$4,797,953,828.92$2,831,666,627.95$1,785,792,199.06
Terminalโ€”3.0%โ€”โ€”โ€”$48,173,002,350.45$30,380,331,834.82
Enterprise Value$53,373,913,809.61
Net Debt$28,229,000,000.00
Equity Value$25,144,913,809.61
Price per Share$10.44
EV/Revenue (Final Year)0.5x
Terminal Value %56.9%
WACC9.7%

๐Ÿฅ Company Financial Health

Historical Revenue Growth4.6%
Current Operating Margin0.0%
FCF Conversion Rate20.9%
Net Debt/Equity0.00
ROE0.0%
ROIC0.0%
Beta1.20
Interest Coverage0.00
Enhanced DCF data sourced from Financial Modeling Prep (FMP) โ€ข Model incorporates industry best practices and academic research โ€ข Calculations are estimates and should not be used as sole investment advice โ€ข Consult with a financial advisor before making investment decisions